Zhong Zhao-Dong, Zou Ping, Huang Shi-Ang, Hu Zhong-Bo, Liu Ling-Bo, Lu Yun-Ping
Institute of Hematology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):238-42.
By using AdEasy system, which is based on the homologous recombination in bacteria, an EGFP labled recombinant adenovirus vector containing hVEGF(165) was generated quickly and its property was studied in vitro. First, hVEGF(165) coding sequence was subcloned into the shuttle plasmid pAdTrack-CMV, then linearized and cotransferred with adenoviral backbone vector pAdEasy-1 into E. coli strain BJ(5183). After positive kanamycin-resistant colony was picked up, the recombinant adenoviral plasmid was identified by restriction analysis with PacI and transfected into HEK 293 cells to assembly replication-defective adenovirus Ad-EGFP/hVEGF(165). The further amplified recombinant adenoviruses were purified by CsCl banding at 32,000 rpm for 18 to 24 hours. Electron microscopy and PCR were performed for testing the recombinant adenovirus. The results showed that the purified particles were homogenous hexagon with a high titer up to 2 x 10(12)pfu/ml. An amplified band of 540 bp fragment demonstrated the successful insert of hVEGF(165). Under fluorescence microscopy, the expression of EGFP was easily detected in HEK 293 and other target cells. The maximal stimulating effect on the proliferation of hUVEC was obtained when the given multiplicity of infection (MOI) of Ad-EGFP/hVEGF(165) was 100. The rate of EGFP positive mouse bone marrow mononuclear cells analysed by flow cytometry was 27.3% after 24 hour-incubation with Ad-EGFP/hVEGF(165) (MOI = 100), and the expression of hVEGF(165) protein in the conditioned medium was 1385 +/- 332 pg/10(6) cells. It is concluded that the construction of adenovirus vector by homologous recombination in bacteria using AdEasy system can be quickly and easily performed, and the prepared high titer of Ad-EGFP/hVEGF(165) is an efficient helpful vector to transfer genes into target cells, all of which make the further in vivo experiments with VEGF(165) possible.
通过使用基于细菌同源重组的AdEasy系统,快速构建了携带人血管内皮生长因子(hVEGF(165))的增强绿色荧光蛋白(EGFP)标记的重组腺病毒载体,并对其体外特性进行了研究。首先,将hVEGF(165)编码序列亚克隆到穿梭质粒pAdTrack-CMV中,然后进行线性化处理,并与腺病毒骨架载体pAdEasy-1共转入大肠杆菌BJ(5183)菌株。挑取卡那霉素抗性阳性菌落,通过PacI酶切分析鉴定重组腺病毒质粒,并将其转染到HEK 293细胞中以组装复制缺陷型腺病毒Ad-EGFP/hVEGF(165)。进一步扩增的重组腺病毒通过在32,000 rpm下进行18至24小时的氯化铯梯度离心进行纯化。通过电子显微镜和聚合酶链反应(PCR)对重组腺病毒进行检测。结果显示,纯化后的病毒颗粒呈均匀的六边形,滴度高达2×10(12)pfu/ml。540 bp片段的扩增条带证明hVEGF(165)成功插入。在荧光显微镜下,在HEK 293细胞和其他靶细胞中很容易检测到EGFP的表达。当Ad-EGFP/hVEGF(165)的感染复数(MOI)为100时,对人脐静脉内皮细胞(hUVEC)增殖的刺激作用最大。用Ad-EGFP/hVEGF(165)(MOI = 100)孵育24小时后,通过流式细胞术分析的EGFP阳性小鼠骨髓单个核细胞率为27.3%,条件培养基中hVEGF(165)蛋白的表达量为1385±332 pg/10(6)细胞。结论是,利用AdEasy系统通过细菌同源重组构建腺病毒载体可以快速简便地进行,制备的高滴度Ad-EGFP/hVEGF(165)是一种将基因导入靶细胞的高效有用载体,所有这些都使得进一步进行VEGF(165)的体内实验成为可能。